chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspnoea, Dysstasia, Heart rate, Lethargy
Clinical narrative: Weak; She cannot get up; Confusion; Shortness of breath; Loss of appetite; Lethargic; Temperature of 99'F; Could not taste anything during dinner; This spontaneous case was reported by a patient family member or friend and describes the occurrence of AGEUSIA (Could not taste anything during dinner), ASTHENIA (Weak), DYSSTASIA (She cannot get up), CONFUSIONAL STATE (Confusion) and DYSPNOEA (Shortness of breath) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hyperthyroidism. Concomitant products included METHIMAZOLE for Hyperthyroidism, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and TOCOPHEROL (VITAMIN E [TOCOPHEROL]) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced AGEUSIA (Could not taste anything during dinner). On 11-Mar-2021, the patient experienced ASTHENIA (Weak), DYSSTASIA (She cannot get up), CONFUSIONAL STATE (Confusion), DYSPNOEA (Shortness of breath), DECREASED APPETITE (Loss of appetite), LETHARGY (Lethargic) and PYREXIA (Temperature of 99'F). At the time of the report, AGEUSIA (Could not taste anything during dinner) had resolved and ASTHENIA (Weak), DYSSTASIA (She cannot get up), CONFUSIONAL STATE (Confusion), DYSPNOEA (Shortness of breath), DECREASED APPETITE (Loss of appetite), LETHARGY (Lethargic) and PYREXIA (Temperature of 99'F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Blood pressure measurement: 106/69 mmHg (Low) 106/69. On 11-Mar-2021, Body temperature: 99°f (High) 99°F. On 11-Mar-2021, Heart rate: 126 (High) 126 beats per minute.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Weak; She cannot get up; Confusion; Shortness of breath; Loss of appetite; Lethargic; Temperature of 99'F; Could not taste anything during dinner; This spontaneous case was reported by a patient family member or friend and describes the occurrence of AGEUSIA (Could not taste anything during dinner), ASTHENIA (Weak), DYSSTASIA (She cannot get up), CONFUSIONAL STATE (Confusion) and DYSPNOEA (Shortness of breath) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hyperthyroidism. Concomitant products included METHIMAZOLE for Hyperthyroidism, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and TOCOPHEROL (VITAMIN E [TOCOPHEROL]) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced AGEUSIA (Could not taste anything during dinner). On 11-Mar-2021, the patient experienced ASTHENIA (Weak), DYSSTASIA (She cannot get up), CONFUSIONAL STATE (Confusion), DYSPNOEA (Shortness of breath), DECREASED APPETITE (Loss of appetite), LETHARGY (Lethargic) and PYREXIA (Temperature of 99'F). At the time of the report, AGEUSIA (Could not taste anything during dinner) had resolved and ASTHENIA (Weak), DYSSTASIA (She cannot get up), CONFUSIONAL STATE (Confusion), DYSPNOEA (Shortness of breath), DECREASED APPETITE (Loss of appetite), LETHARGY (Lethargic) and PYREXIA (Temperature of 99'F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Blood pressure measurement: 106/69 mmHg (Low) 106/69. On 11-Mar-2021, Body temperature: 99°f (High) 99°F. On 11-Mar-2021, Heart rate: 126 (High) 126 beats per minute.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Nausea; Vomiting; Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever). At the time of the report, NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Feeling abnormal, Headache
Clinical narrative: Not to receive the second dose; Brain fog; Numbness; vomiting; tinnitus; lack of eye focus daily; Lightheadedness; Extreme vertigo; Stiff neck; Swollen neck glands; Nausea; Fatigue; Chills; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Extreme vertigo), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEADACHE (Lightheadedness), DIZZINESS (Dizziness) and PRODUCT DOSE OMISSION ISSUE (Not to receive the second dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Mastectomy bilateral (Double mastectomy) and Thyroidectomy. Concurrent medical conditions included Thyroid cancer. Concomitant products included LEVOTHYROXINE and CANDESARTAN for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIZZINESS (Dizziness). On 03-Mar-2021, the patient experienced VERTIGO (Extreme vertigo), MUSCULOSKELETAL STIFFNESS (Stiff neck), LYMPHADENOPATHY (Swollen neck glands), NAUSEA (Nausea), FATIGUE (Fatigue) and CHILLS (Chills). On 12-Mar-2021, the patient experienced HEADACHE (Lightheadedness). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not to receive the second dose), FEELING ABNORMAL (Brain fog), HYPOAESTHESIA (Numbness), VOMITING (vomiting), TINNITUS (tinnitus) and VISION BLURRED (lack of eye focus daily). On 12-Mar-2021, VERTIGO (Extreme vertigo), DIZZINESS (Dizziness), LYMPHADENOPATHY (Swollen neck glands), NAUSEA (Nausea), FATIGUE (Fatigue) and CHILLS (Chills) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiff neck), HEADACHE (Lightheadedness) and FEELING ABNORMAL (Brain fog) had resolved with sequelae and PRODUCT DOSE OMISSION ISSUE (Not to receive the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       In follow up patient reported that patient did not take the second dose of vaccine The patient sought medical attention and a physician examined the patient's ears and sinus and there was no sign of infection.  Patient was prescribed Meclizine to treat her symptoms however, she had not taken any of the medication at the time of the report.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Significant follow up received on 22-jun-2021 , with events added , event updated and reporter details updated
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Lymphadenopathy, Musculoskeletal stiffness, Nausea, Product dose omission issue
Clinical narrative: Not to receive the second dose; Brain fog; Numbness; vomiting; tinnitus; lack of eye focus daily; Lightheadedness; Extreme vertigo; Stiff neck; Swollen neck glands; Nausea; Fatigue; Chills; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Extreme vertigo), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEADACHE (Lightheadedness), DIZZINESS (Dizziness) and PRODUCT DOSE OMISSION ISSUE (Not to receive the second dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Mastectomy bilateral (Double mastectomy) and Thyroidectomy. Concurrent medical conditions included Thyroid cancer. Concomitant products included LEVOTHYROXINE and CANDESARTAN for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIZZINESS (Dizziness). On 03-Mar-2021, the patient experienced VERTIGO (Extreme vertigo), MUSCULOSKELETAL STIFFNESS (Stiff neck), LYMPHADENOPATHY (Swollen neck glands), NAUSEA (Nausea), FATIGUE (Fatigue) and CHILLS (Chills). On 12-Mar-2021, the patient experienced HEADACHE (Lightheadedness). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not to receive the second dose), FEELING ABNORMAL (Brain fog), HYPOAESTHESIA (Numbness), VOMITING (vomiting), TINNITUS (tinnitus) and VISION BLURRED (lack of eye focus daily). On 12-Mar-2021, VERTIGO (Extreme vertigo), DIZZINESS (Dizziness), LYMPHADENOPATHY (Swollen neck glands), NAUSEA (Nausea), FATIGUE (Fatigue) and CHILLS (Chills) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiff neck), HEADACHE (Lightheadedness) and FEELING ABNORMAL (Brain fog) had resolved with sequelae and PRODUCT DOSE OMISSION ISSUE (Not to receive the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       In follow up patient reported that patient did not take the second dose of vaccine The patient sought medical attention and a physician examined the patient's ears and sinus and there was no sign of infection.  Patient was prescribed Meclizine to treat her symptoms however, she had not taken any of the medication at the time of the report.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Significant follow up received on 22-jun-2021 , with events added , event updated and reporter details updated
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vertigo, Vision blurred, Vomiting
Clinical narrative: Not to receive the second dose; Brain fog; Numbness; vomiting; tinnitus; lack of eye focus daily; Lightheadedness; Extreme vertigo; Stiff neck; Swollen neck glands; Nausea; Fatigue; Chills; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Extreme vertigo), MUSCULOSKELETAL STIFFNESS (Stiff neck), HEADACHE (Lightheadedness), DIZZINESS (Dizziness) and PRODUCT DOSE OMISSION ISSUE (Not to receive the second dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Mastectomy bilateral (Double mastectomy) and Thyroidectomy. Concurrent medical conditions included Thyroid cancer. Concomitant products included LEVOTHYROXINE and CANDESARTAN for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIZZINESS (Dizziness). On 03-Mar-2021, the patient experienced VERTIGO (Extreme vertigo), MUSCULOSKELETAL STIFFNESS (Stiff neck), LYMPHADENOPATHY (Swollen neck glands), NAUSEA (Nausea), FATIGUE (Fatigue) and CHILLS (Chills). On 12-Mar-2021, the patient experienced HEADACHE (Lightheadedness). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not to receive the second dose), FEELING ABNORMAL (Brain fog), HYPOAESTHESIA (Numbness), VOMITING (vomiting), TINNITUS (tinnitus) and VISION BLURRED (lack of eye focus daily). On 12-Mar-2021, VERTIGO (Extreme vertigo), DIZZINESS (Dizziness), LYMPHADENOPATHY (Swollen neck glands), NAUSEA (Nausea), FATIGUE (Fatigue) and CHILLS (Chills) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiff neck), HEADACHE (Lightheadedness) and FEELING ABNORMAL (Brain fog) had resolved with sequelae and PRODUCT DOSE OMISSION ISSUE (Not to receive the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       In follow up patient reported that patient did not take the second dose of vaccine The patient sought medical attention and a physician examined the patient's ears and sinus and there was no sign of infection.  Patient was prescribed Meclizine to treat her symptoms however, she had not taken any of the medication at the time of the report.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Significant follow up received on 22-jun-2021 , with events added , event updated and reporter details updated
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain at injection site) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced INJECTION SITE PAIN (Pain at injection site). At the time of the report, INJECTION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was reported by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Heart rate abnormal, Pyrexia
Clinical narrative: resting heart rate fluctuating between 94-127; running a fever 100.5; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE ABNORMAL (resting heart rate fluctuating between 94-127), PYREXIA (running a fever 100.5) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE ABNORMAL (resting heart rate fluctuating between 94-127), PYREXIA (running a fever 100.5) and HEADACHE (headache). At the time of the report, HEART RATE ABNORMAL (resting heart rate fluctuating between 94-127), PYREXIA (running a fever 100.5) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  Treatment details were not provided.    Reporter did not allow further contact
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Adnexa uteri pain, Anxiety, Cough, Depressed mood
Clinical narrative: Bloating; Mood Swings; Pain in ovary; Sore throat; Coughing; Gasping,Unable to breath; Unwell Feeling; Hot and Sweaty; Fatigue; Low fever; Anxiety; Worse than depression; Disorientation; Wave of dizziness; Wave of hopelessness; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), DEPRESSED MOOD (Worse than depression), DISORIENTATION (Disorientation), DIZZINESS (Wave of dizziness) and FEELING OF DESPAIR (Wave of hopelessness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Cortisone cephalexin.), Osteoarthritis, Hypothyroidism and Blood pressure immeasurable. Concomitant products included OLMESARTAN, LEVOTHYROXINE, DOXYCYCLINE HYDROCHLORIDE, LORATADINE, MULTIVITAMINS [VITAMINS NOS], VITAMIN D [VITAMIN D NOS], UBIDECARENONE (COQ 10), TRAMADOL HCL and DICLOFENAC SODIUM for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ANXIETY (Anxiety), DEPRESSED MOOD (Worse than depression), DISORIENTATION (Disorientation), DIZZINESS (Wave of dizziness) and FEELING OF DESPAIR (Wave of hopelessness). On an unknown date, the patient experienced ABDOMINAL DISTENSION (Bloating), MOOD SWINGS (Mood Swings), ADNEXA UTERI PAIN (Pain in ovary), OROPHARYNGEAL PAIN (Sore throat), COUGH (Coughing), DYSPNOEA (Gasping,Unable to breath), MALAISE (Unwell Feeling), HYPERHIDROSIS (Hot and Sweaty), FATIGUE (Fatigue) and PYREXIA (Low fever). On 02-Mar-2021, ANXIETY (Anxiety) and DISORIENTATION (Disorientation) had resolved with sequelae, DEPRESSED MOOD (Worse than depression) and FEELING OF DESPAIR (Wave of hopelessness) had resolved. At the time of the report, DIZZINESS (Wave of dizziness), ABDOMINAL DISTENSION (Bloating), MOOD SWINGS (Mood Swings), ADNEXA UTERI PAIN (Pain in ovary), OROPHARYNGEAL PAIN (Sore throat), COUGH (Coughing), DYSPNOEA (Gasping,Unable to breath), MALAISE (Unwell Feeling), HYPERHIDROSIS (Hot and Sweaty), FATIGUE (Fatigue) and PYREXIA (Low fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: VAERS form uploaded: Medical history, Concomitants, Event outcomes updated. On 06-Aug-2021: Follow-up received: New events and outcomes were added.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Dizziness, Dyspnoea, Fatigue, Feeling of despair
Clinical narrative: Bloating; Mood Swings; Pain in ovary; Sore throat; Coughing; Gasping,Unable to breath; Unwell Feeling; Hot and Sweaty; Fatigue; Low fever; Anxiety; Worse than depression; Disorientation; Wave of dizziness; Wave of hopelessness; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), DEPRESSED MOOD (Worse than depression), DISORIENTATION (Disorientation), DIZZINESS (Wave of dizziness) and FEELING OF DESPAIR (Wave of hopelessness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Cortisone cephalexin.), Osteoarthritis, Hypothyroidism and Blood pressure immeasurable. Concomitant products included OLMESARTAN, LEVOTHYROXINE, DOXYCYCLINE HYDROCHLORIDE, LORATADINE, MULTIVITAMINS [VITAMINS NOS], VITAMIN D [VITAMIN D NOS], UBIDECARENONE (COQ 10), TRAMADOL HCL and DICLOFENAC SODIUM for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ANXIETY (Anxiety), DEPRESSED MOOD (Worse than depression), DISORIENTATION (Disorientation), DIZZINESS (Wave of dizziness) and FEELING OF DESPAIR (Wave of hopelessness). On an unknown date, the patient experienced ABDOMINAL DISTENSION (Bloating), MOOD SWINGS (Mood Swings), ADNEXA UTERI PAIN (Pain in ovary), OROPHARYNGEAL PAIN (Sore throat), COUGH (Coughing), DYSPNOEA (Gasping,Unable to breath), MALAISE (Unwell Feeling), HYPERHIDROSIS (Hot and Sweaty), FATIGUE (Fatigue) and PYREXIA (Low fever). On 02-Mar-2021, ANXIETY (Anxiety) and DISORIENTATION (Disorientation) had resolved with sequelae, DEPRESSED MOOD (Worse than depression) and FEELING OF DESPAIR (Wave of hopelessness) had resolved. At the time of the report, DIZZINESS (Wave of dizziness), ABDOMINAL DISTENSION (Bloating), MOOD SWINGS (Mood Swings), ADNEXA UTERI PAIN (Pain in ovary), OROPHARYNGEAL PAIN (Sore throat), COUGH (Coughing), DYSPNOEA (Gasping,Unable to breath), MALAISE (Unwell Feeling), HYPERHIDROSIS (Hot and Sweaty), FATIGUE (Fatigue) and PYREXIA (Low fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: VAERS form uploaded: Medical history, Concomitants, Event outcomes updated. On 06-Aug-2021: Follow-up received: New events and outcomes were added.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Malaise, Mood swings, Oropharyngeal pain, Pyrexia
Clinical narrative: Bloating; Mood Swings; Pain in ovary; Sore throat; Coughing; Gasping,Unable to breath; Unwell Feeling; Hot and Sweaty; Fatigue; Low fever; Anxiety; Worse than depression; Disorientation; Wave of dizziness; Wave of hopelessness; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), DEPRESSED MOOD (Worse than depression), DISORIENTATION (Disorientation), DIZZINESS (Wave of dizziness) and FEELING OF DESPAIR (Wave of hopelessness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Cortisone cephalexin.), Osteoarthritis, Hypothyroidism and Blood pressure immeasurable. Concomitant products included OLMESARTAN, LEVOTHYROXINE, DOXYCYCLINE HYDROCHLORIDE, LORATADINE, MULTIVITAMINS [VITAMINS NOS], VITAMIN D [VITAMIN D NOS], UBIDECARENONE (COQ 10), TRAMADOL HCL and DICLOFENAC SODIUM for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ANXIETY (Anxiety), DEPRESSED MOOD (Worse than depression), DISORIENTATION (Disorientation), DIZZINESS (Wave of dizziness) and FEELING OF DESPAIR (Wave of hopelessness). On an unknown date, the patient experienced ABDOMINAL DISTENSION (Bloating), MOOD SWINGS (Mood Swings), ADNEXA UTERI PAIN (Pain in ovary), OROPHARYNGEAL PAIN (Sore throat), COUGH (Coughing), DYSPNOEA (Gasping,Unable to breath), MALAISE (Unwell Feeling), HYPERHIDROSIS (Hot and Sweaty), FATIGUE (Fatigue) and PYREXIA (Low fever). On 02-Mar-2021, ANXIETY (Anxiety) and DISORIENTATION (Disorientation) had resolved with sequelae, DEPRESSED MOOD (Worse than depression) and FEELING OF DESPAIR (Wave of hopelessness) had resolved. At the time of the report, DIZZINESS (Wave of dizziness), ABDOMINAL DISTENSION (Bloating), MOOD SWINGS (Mood Swings), ADNEXA UTERI PAIN (Pain in ovary), OROPHARYNGEAL PAIN (Sore throat), COUGH (Coughing), DYSPNOEA (Gasping,Unable to breath), MALAISE (Unwell Feeling), HYPERHIDROSIS (Hot and Sweaty), FATIGUE (Fatigue) and PYREXIA (Low fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: VAERS form uploaded: Medical history, Concomitants, Event outcomes updated. On 06-Aug-2021: Follow-up received: New events and outcomes were added.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: fever; CHILLS; HEADACHE; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (CHILLS) and HEADACHE (HEADACHE) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MELOXICAM and IBUPROFEN for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (fever), CHILLS (CHILLS) and HEADACHE (HEADACHE). At the time of the report, PYREXIA (fever) and CHILLS (CHILLS) had resolved and HEADACHE (HEADACHE) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant medications reported included 2 heart medications and a cholesterol medication since unknown start dates for unknown indications.  Treatment medication reported included acetaminophen (Tylenol) for headache since 09-Mar-2021.
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Gait disturbance
Clinical narrative: her arthritis pain has intensified every day ever since she received the vaccine; she can barely walk now; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (her arthritis pain has intensified every day ever since she received the vaccine) and GAIT DISTURBANCE (she can barely walk now) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No concomitant medications reported.  Concurrent medical conditions included Arthritis and Joint pain.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced ARTHRITIS (her arthritis pain has intensified every day ever since she received the vaccine) and GAIT DISTURBANCE (she can barely walk now). At the time of the report, ARTHRITIS (her arthritis pain has intensified every day ever since she received the vaccine) and GAIT DISTURBANCE (she can barely walk now) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided. Patient has arthritis and join pain. She was administered the vaccine on 08Feb2021. She states that her arthritis pain has intensified every day ever since she received the vaccine and she can barely walk at all now
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, SARS-CoV-2 test
Clinical narrative: Loss of taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concomitant products included CARVEDILOL, ACETYLSALICYLIC ACID (ASPIRINE), FUROSEMIDE, SPIRONOLACTONE, RANOLAZINE, RAMIPRIL, ATORVASTATIN, FISH OIL, CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]), CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM + VIT D), IRON and ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION) for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced AGEUSIA (Loss of taste). At the time of the report, AGEUSIA (Loss of taste) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Pyrexia, Sleep disorder, Vaccination site pruritus
Clinical narrative: itching at the site of the injection; diarrhea; headache; fever; was in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (was in bed all day), DIARRHOEA (diarrhea), HEADACHE (headache), PYREXIA (fever) and VACCINATION SITE PRURITUS (itching at the site of the injection) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 300042698 and 300042722) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced SLEEP DISORDER (was in bed all day), HEADACHE (headache) and PYREXIA (fever). On 10-Mar-2021, the patient experienced DIARRHOEA (diarrhea). On 11-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the site of the injection). On 10-Mar-2021, SLEEP DISORDER (was in bed all day), DIARRHOEA (diarrhea), HEADACHE (headache) and PYREXIA (fever) had resolved. On 12-Mar-2021, VACCINATION SITE PRURITUS (itching at the site of the injection) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment details included Bite Ointment.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Gait disturbance
Clinical narrative: significant loss of energy; unsteady on their feet; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (significant loss of energy) and GAIT DISTURBANCE (unsteady on their feet) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Patient's medical history included No Adverse event.  Concomitant products included LAMOTRIGINE and METOCLOPRAMIDE HYDROCHLORIDE (CLOPAN) for an unknown indication.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced ASTHENIA (significant loss of energy) and GAIT DISTURBANCE (unsteady on their feet). At the time of the report, ASTHENIA (significant loss of energy) and GAIT DISTURBANCE (unsteady on their feet) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: soreness in arm, achey arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm, achey arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in arm, achey arm). At the time of the report, PAIN IN EXTREMITY (soreness in arm, achey arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site urticaria, Vaccination site warmth
Clinical narrative: the injection site was warm to touch; I have a giant red spot like a welt about 4 inches by 5 inches kind of an oval; I have a giant red spot like a welt about 4 inches by 5 inches kind of an oval; tenderness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (the injection site was warm to touch), VACCINATION SITE PAIN (tenderness at the injection site), VACCINATION SITE ERYTHEMA (I have a giant red spot like a welt about 4 inches by 5 inches kind of an oval) and VACCINATION SITE URTICARIA (I have a giant red spot like a welt about 4 inches by 5 inches kind of an oval) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's medical history information was not provided.  Concomitant products included AMLODIPINE for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (tenderness at the injection site). On 13-Mar-2021, the patient experienced VACCINATION SITE WARMTH (the injection site was warm to touch), VACCINATION SITE ERYTHEMA (I have a giant red spot like a welt about 4 inches by 5 inches kind of an oval) and VACCINATION SITE URTICARIA (I have a giant red spot like a welt about 4 inches by 5 inches kind of an oval). At the time of the report, VACCINATION SITE WARMTH (the injection site was warm to touch), VACCINATION SITE PAIN (tenderness at the injection site), VACCINATION SITE ERYTHEMA (I have a giant red spot like a welt about 4 inches by 5 inches kind of an oval) and VACCINATION SITE URTICARIA (I have a giant red spot like a welt about 4 inches by 5 inches kind of an oval) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Periorbital swelling, Peripheral swelling, Ultrasound scan
Clinical narrative: swelling on my wrist up to the bend of my arm; swollen pockets under eyes; Large Lumps on both arms/ lumps under my elbow; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Large Lumps on both arms/ lumps under my elbow), PERIPHERAL SWELLING (swelling on my wrist up to the bend of my arm) and PERIORBITAL SWELLING (swollen pockets under eyes) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MASS (Large Lumps on both arms/ lumps under my elbow). On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling on my wrist up to the bend of my arm) and PERIORBITAL SWELLING (swollen pockets under eyes). At the time of the report, MASS (Large Lumps on both arms/ lumps under my elbow), PERIPHERAL SWELLING (swelling on my wrist up to the bend of my arm) and PERIORBITAL SWELLING (swollen pockets under eyes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information, if any, was not provided by the reporter.  On an unknown date, the patient's physician performed an x-ray to see if the patient had blood clots and it was reported that there were no blood clots.  Treatment information, if any, was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: TCR follow up received: AE's added
Sex: F
Vaccine: COVID19
Symptoms: Breast pain
Clinical narrative: severe pain across the top of her breast; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (severe pain across the top of her breast) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced BREAST PAIN (severe pain across the top of her breast). At the time of the report, BREAST PAIN (severe pain across the top of her breast) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided. Concomitant medications included. medicine for blood pressure, cholesterol and diabetes.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysgeusia, Dyspnoea, Hypoaesthesia, Musculoskeletal stiffness
Clinical narrative: light headedness; dizziness; difficulty of breathing; swelling of the throat; stiffness at the back of the neck; facial numbness (lips); tingling sensation of the jaw; a little bit shaky; arm soreness; nausea; inconsistent metallic taste; swelling of the tonsils; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headedness), DIZZINESS (dizziness), DYSPNOEA (difficulty of breathing), PHARYNGEAL SWELLING (swelling of the throat) and MUSCULOSKELETAL STIFFNESS (stiffness at the back of the neck) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIZZINESS (light headedness), DIZZINESS (dizziness), DYSPNOEA (difficulty of breathing), PHARYNGEAL SWELLING (swelling of the throat), MUSCULOSKELETAL STIFFNESS (stiffness at the back of the neck), HYPOAESTHESIA (facial numbness (lips)), PARAESTHESIA (tingling sensation of the jaw), TREMOR (a little bit shaky), PAIN IN EXTREMITY (arm soreness), NAUSEA (nausea), DYSGEUSIA (inconsistent metallic taste) and TONSILLAR HYPERTROPHY (swelling of the tonsils). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (light headedness), DIZZINESS (dizziness), DYSPNOEA (difficulty of breathing), PHARYNGEAL SWELLING (swelling of the throat), MUSCULOSKELETAL STIFFNESS (stiffness at the back of the neck), HYPOAESTHESIA (facial numbness (lips)), PARAESTHESIA (tingling sensation of the jaw), PAIN IN EXTREMITY (arm soreness), NAUSEA (nausea), DYSGEUSIA (inconsistent metallic taste) and TONSILLAR HYPERTROPHY (swelling of the tonsils) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Took as Vertec.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Paraesthesia, Pharyngeal swelling, Tonsillar hypertrophy
Clinical narrative: light headedness; dizziness; difficulty of breathing; swelling of the throat; stiffness at the back of the neck; facial numbness (lips); tingling sensation of the jaw; a little bit shaky; arm soreness; nausea; inconsistent metallic taste; swelling of the tonsils; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headedness), DIZZINESS (dizziness), DYSPNOEA (difficulty of breathing), PHARYNGEAL SWELLING (swelling of the throat) and MUSCULOSKELETAL STIFFNESS (stiffness at the back of the neck) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIZZINESS (light headedness), DIZZINESS (dizziness), DYSPNOEA (difficulty of breathing), PHARYNGEAL SWELLING (swelling of the throat), MUSCULOSKELETAL STIFFNESS (stiffness at the back of the neck), HYPOAESTHESIA (facial numbness (lips)), PARAESTHESIA (tingling sensation of the jaw), TREMOR (a little bit shaky), PAIN IN EXTREMITY (arm soreness), NAUSEA (nausea), DYSGEUSIA (inconsistent metallic taste) and TONSILLAR HYPERTROPHY (swelling of the tonsils). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (light headedness), DIZZINESS (dizziness), DYSPNOEA (difficulty of breathing), PHARYNGEAL SWELLING (swelling of the throat), MUSCULOSKELETAL STIFFNESS (stiffness at the back of the neck), HYPOAESTHESIA (facial numbness (lips)), PARAESTHESIA (tingling sensation of the jaw), PAIN IN EXTREMITY (arm soreness), NAUSEA (nausea), DYSGEUSIA (inconsistent metallic taste) and TONSILLAR HYPERTROPHY (swelling of the tonsils) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Took as Vertec.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: light headedness; dizziness; difficulty of breathing; swelling of the throat; stiffness at the back of the neck; facial numbness (lips); tingling sensation of the jaw; a little bit shaky; arm soreness; nausea; inconsistent metallic taste; swelling of the tonsils; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headedness), DIZZINESS (dizziness), DYSPNOEA (difficulty of breathing), PHARYNGEAL SWELLING (swelling of the throat) and MUSCULOSKELETAL STIFFNESS (stiffness at the back of the neck) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIZZINESS (light headedness), DIZZINESS (dizziness), DYSPNOEA (difficulty of breathing), PHARYNGEAL SWELLING (swelling of the throat), MUSCULOSKELETAL STIFFNESS (stiffness at the back of the neck), HYPOAESTHESIA (facial numbness (lips)), PARAESTHESIA (tingling sensation of the jaw), TREMOR (a little bit shaky), PAIN IN EXTREMITY (arm soreness), NAUSEA (nausea), DYSGEUSIA (inconsistent metallic taste) and TONSILLAR HYPERTROPHY (swelling of the tonsils). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (light headedness), DIZZINESS (dizziness), DYSPNOEA (difficulty of breathing), PHARYNGEAL SWELLING (swelling of the throat), MUSCULOSKELETAL STIFFNESS (stiffness at the back of the neck), HYPOAESTHESIA (facial numbness (lips)), PARAESTHESIA (tingling sensation of the jaw), PAIN IN EXTREMITY (arm soreness), NAUSEA (nausea), DYSGEUSIA (inconsistent metallic taste) and TONSILLAR HYPERTROPHY (swelling of the tonsils) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Took as Vertec.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN (Body aches). The patient was treated with PARACETAMOL (TYLENOL) for General body pain, at an unspecified dose and frequency. On 13-Mar-2021, PAIN (Body aches) had resolved.            No relevant concomitant medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow-up information received on 29 Jun 2021 contains non-significant information.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Still warm/warm at injection site; Arm itchy at the injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Still warm/warm at injection site), VACCINATION SITE PRURITUS (Arm itchy at the injection site) and PYREXIA (Fever) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure (High blood pressure was reported), Thyroid disorder NOS (The reporter states that the patient takes thyroid medication) and Cardiac disorder NOS (The reporter states that the patient is on heart medications.).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Still warm/warm at injection site), VACCINATION SITE PRURITUS (Arm itchy at the injection site) and PYREXIA (Fever). At the time of the report, VACCINATION SITE WARMTH (Still warm/warm at injection site), VACCINATION SITE PRURITUS (Arm itchy at the injection site) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included blood thinner, high blood pressure medication, thyroid medications and heart medicines.  No treatment information was reported. Patient received the first dose of moderna vaccine on 9 March2021 and had arm itchy and fever at injection site. Started couple days after the shot, maybe next day. Still on going, still warm   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: NNI